Immunologic Techniques

Name
Immunologic Techniques
Accession Number
DBCAT005078
Description

Techniques used to demonstrate or measure an immune response, and to identify or measure antigens using antibodies.

Drugs
DrugDrug Description
Brexucabtagene autoleucelA modified autologous chimeric antigen receptor (CAR) T cell therapy employing a modified murine anti-CD19 single-chain variable fragment linked to CD28 and CD3ΞΆ co-stimulatory domains for the treatment of patients with relapsed and refractory mantle cell lymphoma.
Drugs & Drug Targets
DrugTargetType
Brexucabtagene autoleucelB-lymphocyte antigen CD19target